Navigation Links
Trubion Pharmaceuticals to Present at Upcoming Investor Conferences
Date:9/4/2007

Dr. Peter Thompson to Present at BioCentury's Newsmakers in the Biotech Industry, Bank of America Investment, and UBS Global Life Sciences Investor

Conferences

SEATTLE, Sept. 4 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN) announced today that Dr. Peter Thompson, president, chief executive officer, and chairman of Trubion, will present an overview of the company at three September investor conferences:

-- BioCentury's NewsMakers in the Biotech Industry conference at the

Millennium Broadway Hotel & Conference Center, 145 W. 44th St., New

York. Dr. Thompson is scheduled to present on Thursday, Sept. 6. A

webcast of the presentation will be available at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=TRBN&item_id=16304 70.

-- Bank of America 37th Annual Investment Conference at the Ritz-Carlton,

600 Stockton St. (at California St.), San Francisco. Dr. Thompson is

scheduled to present on Monday, Sept. 17. A webcast of the presentation

will be available at

http://www.veracast.com/webcasts/bas/37th-annual-2007/id22113469.cfm.

-- UBS Global Life Sciences Investor Conference at the Grand Hyatt, 109 E.

42nd St. (at Grand Central Station), New York. Dr. Thompson is

scheduled to present on Monday, Sept. 24. A webcast of the presentation

will be available at

http:/
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
4. Wisconsin firms to present at Cleantech venture capital event
5. New Sonic Foundry search engine finds words, phrases in video presentations
6. Lone Wisconsin firm to present at InvestMidwest
7. Sonic Foundry creates search engine for 7,000 expert video presentations
8. InvestMidWest calls for business presentations
9. Wicab to present BrainPort at Boston conference
10. Three more Wisconsin firms to present at venture forum
11. Six Wisconsin firms to present at BIO Mid-America VentureForum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Follow us on LinkedIn ... available in abundance in nature. These natural bio-based ... as shells of crustaceans. The significant commercial interest ... the high percentage of nitrogen present compared to ... industries owing to its exclusive properties such as ...
(Date:9/22/2014)... TORONTO , Sept. 22, 2014 ... announced that it has entered into a collaboration ... UHN,s Centre for Molecular Design and Preformulations (CMDP) ... The goal of the project is to increase ... proprietary buccal insulin spray product, thereby reducing the ...
(Date:9/22/2014)... , September 22, 2014 The ... a mixed note as the Dow Jones Industrial Average ... closed at 4,579.79, down 0.30%. The S&P 500 finished ... session, six out of ten sectors finished on a ... ended the day at 751.48, up 0.10%, with the ...
(Date:9/21/2014)... University of Basel in Switzerland have succeeded in ... molecule for the first time. These extremely weak ... molecular properties and may also contribute to the ... results were published in the scientific journal ... the interaction between matter and light, is probably ...
Breaking Biology Technology:Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 2Emergence of New Application Areas to Drive the Global Chitin and Chitosan Market, According to New Report by Global Industry Analysts, Inc. 3Generex Collaborates with University Health Network for Buccal Insulin Project 2Generex Collaborates with University Health Network for Buccal Insulin Project 3Generex Collaborates with University Health Network for Buccal Insulin Project 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5Uncovering the forbidden side of molecules 2
... up a limbo line for the WTN readership. The question is ... high tech off the ground in your organization. , ,What got ... theft stories. Turns out the perps are not the archetypal Dorito-munching, ... In one case a bank gave its customer list to some ...
... alarums and excursions relevant to the world of Midwest ... ,Last week, the Midwest Venture Summit was held in ... 10 were sponsored by the Chicago chapter of the ... were registered to attend, an unofficial count estimated that ...
... could bring better, safer treatments to cancer patients worldwide might ... firm with more than 200 employees that has grown to ... its founder said. , ,The company is run by Thomas ... commercial when GE Medical cut off its funding for his ...
Cached Biology Technology:How low (tech) must you go? 2How low (tech) must you go? 3Midwest Venture Summit disappoints; Cato grades Midwest governors 2Midwest Venture Summit disappoints; Cato grades Midwest governors 3Midwest Venture Summit disappoints; Cato grades Midwest governors 4TomoTherapy considers IPO with medical-device business on the rise 2TomoTherapy considers IPO with medical-device business on the rise 3
(Date:9/21/2014)... CAMBRIDGE, MA -- In recent years, new strains of ... antibiotics. Each year, these superbugs, including drug-resistant forms of ... nationwide, and kill at least 23,000. Despite the urgent ... new classes of antibiotics in the past decade. , ... on these superbugs. Using a gene-editing system that can ...
(Date:9/21/2014)... A team of Stanford researchers has developed a protein ... to break away from original tumor sites, travel through ... in the body. , This process, known as metastasis, ... , "The majority of patients who succumb to cancer ... Jennifer Cochran, an associate professor of bioengineering who describes ...
(Date:9/19/2014)... Oklahoma biology professor will study the unique bioelectric signaling ... eventually benefit people,s health. The OU researcher is ... required to produce the signals used to map the ... at a rate of 500-600 discharges a second throughout ... electric fish are extreme, but necessary for survival. , ...
Breaking Biology News(10 mins):Battling superbugs 2Battling superbugs 3Battling superbugs 4Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4
... a common feature of prion disease-affected human, mouse, and ... Neena Singh and colleagues at Case Western Reserve University ... findings, published March 13 in the open-access journal ... of neurotoxicity in prion disorders, and novel avenues for ...
... Kansas State,University, with collaboration from Epitopix LLC, have ... E. coli O157 in beef cattle. ... the post-harvest food safety,aspect, whether it,s E. ... College of Veterinary Medicine. Thomson is the Jones,Professor ...
... German . The Aarhus University ... between the many conference participants and according to ... Kyoto was very successful in doing so: "I am ... will undoubtedly contribute significantly to the future climate debate ...
Cached Biology News:Iron is involved in prion disease-associated neuronal demise 2K-State researchers help Epitopix license the United States' first E. coli O157 vaccine for cattle 2Seven recommendations from Aarhus to COP15 2Seven recommendations from Aarhus to COP15 3
Vybrant® Multidrug Resistance Assay Kit...
...
... CultureWell cell culture systems provide an ... for staining and imaging. Each system ... standard optical-quality coverslips in cell culture ... sterile and ready to use. Individual ...
... of DETACHaBEAD Mouse CD4, polyclonal Sheep anti-Mouse ... from Dynabeads Mouse CD4 (L3T4). Detach ... Dynabeads Mouse CD4 using DETACHaBEAD Mouse CD4. ... downstream application including flow cytometry, functional studies ...
Biology Products: